Mucosal Origin of Autoimmunity Flashcards

1
Q

what is the structure of the surface of the colon?

A

Single cell layer thick barrier between 10^13 bacteria and body - fragile
- Thin barrier is maintained – bilayer of mucous prevents entry of bacteria
- Enormous gut surface full of bacteria – prevents bacteria entering, but enables uptake of metabolites from bacteria to supply immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

how does the gut microbiome engage with the immune system?

A
  • Epithelial layer of gut
  • Large surface – 400 square meters which can engage/interact with bacteria
  • M cells – specialised in small particle uptake (not bacteria) to interact with immune system – interaction occurs in nodule follicles sitting beneath surface which function like mini lymph nodes – first place where immune system interacts with bacteria of gut
  • Mesenchymal draining lymph nodes with T and B cell zones – control immune tolerance to bacteria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

why are interactions with the microbiome crucial?

A
  • Don’t want an immune response to these bacteria as it is a symbiotic relationship with microbiota
  • Interaction with healthy microbiome is crucial – metabolites produced by microbiome directly regulate lymphocyte gene transcription
  • complex crosstalk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

how can autoimmunity be triggered in the gut?

A

Unbalanced interaction with microbiota can lead to inflammation in the gut and triggering of autoimmunity
- e.g. colitis and Crohn’s
- Fine balance of microbiome and immune system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

where can interactions with the gut microbiome go wrong?

A
  • Balance between Tregs and Th17 T cells can go wrong – induces gut inflammation – T cell regulation/homeostasis is crucial
  • Disequilibrium in response to bacteria - lack of regulation
  • Defects in the thin mucosal barrier

All of these can induce autoreactive T and B cell responses – autoantibody production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what are the roles of the mucosa in initiation of autoimmunity (AI)?

A
  • it is the site of initial contact and as portal of entry - some bacteria that enter may be more pro-inflammatory
  • it regulates susceptibility to AI - can form regional ectopic tertiary lymphoid structures
  • there may be cross-reactivity between foreign and self antigens - molecular mimicry
  • alteration of self proteins e.g. citrullination in RA - Modified proteins from neutrophils – AI response to these proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is a common theme in arthritis?

A
  • damage or dysfunction may occur at the entry surfaces for bacteria, which can lead to increased risk of arthritis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how is inflammatory bowel disease (IBD) linked to arthritis?

A

40% IBD patients tend to develop enteropathic arthritis - chronic inflammation of joints, similar to RA, but different autoantibodies
- loss of barrier function
- Gut permeability and inflammation can trigger destructive arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

how are periodontitis and arthritis linked?

A

Close association between gum health and RA – patients with RA have high risk of periodontitis and vice versa
- gum inflammation and tooth loss and RA are highly associated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

how is psoriasis linked with arthritis?

A

Psoriatic arthritis – psoriasis = inflammatory response in skin – 30% of these patients can also develop psoriatic arthritis long term – different autoantibodies, so not same as RA
- chronic, destructive joint disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what tends to be a patient’s journey towards RA?

A

1st hit: environmental or genetic risk factor
- e.g. HLA-DRB1, or smoking

2nd hit: development of anti-CCPs due to increased citrullination - can still be healthy, so aren’t yet diagnosed
- could treat these people but difficult - need to consider scale of risk and side effects

3rd hit: may develop swelling at finger joints over the next few years

4th hit: meet full diagnostic criteria for RA: swollen joints and anti-CCP
- disease progression can take time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are ACPA?

A

anti-citrullinated protein antibodies
- Anti-CCP recognise neoantigen of arginine residue being modified by PAD which can remove amino group to produce modified residue citrulline
- PAD requires calcium
- Citrulline is not made de novo, it is generated by this secondary modification by PAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

how is ACPA implicated in RA?

A
  • highly specific, found in 50-70% of RA patients
  • detected years before onset of symptoms
  • correlated with disease severity
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

are all patients seropositive for ACPA?

A

no, there are seronegative patients which lack anti-CCP

More anti-CCP = more likely to develop worse RA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what has been implicated to produce citrullinated autoantigens?

A

Samples from RA joints – found NET structures (neutrophils spill out chromatin to capture bacteria and prevent them spreading)
- Lots of neutrophils and NETs in joints of RA patients
- In the patient NETs, there are high CCP levels
- neutrophils generate the CCP autoantigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

how do neutrophils produce citrullinated peptides?

A

To release NETs, PAD is activated in neutrophils, leading to citrullination of arginine side chains in proteins such as collagen II, fibrinogen
- Autoantibodies form immune complexes with CCPs on NETs
– these proinflammatory complexes will lead to phagocytosis by macrophages to act as APCs for the adaptive response, leading to further adaptive mobilisation

17
Q

how does autoimmunity travel from the mucosa to the joints?

A

Inflammatory trigger in gut leads to the production of CCP antigens
- This leads to ACPA response
- Inflammatory response may occur a while before the development of RA symptoms
- ACPA antibodies can be in healthy people
- then second inflammatory hit in joint causes neutrophils to infiltrate the joint
- existing ACPA form immune complexes with CCP in NETs and induce uptake of neoantigens

18
Q

what cytokines are produced in RA joints?

A

Sorted cell populations from synovial fluid for cytokine mRNA:
- Neutrophils produce pro-inflammatory cytokines in RA e.g. IL-1B (doesn’t just produce NETs, also drives inflammation in joint)
- In B cells, there is massive production of RANK ligand = cytokine which can cause bone damage

19
Q

what B cell population expresses RANKL?

A

New B cell population in joint:
- expresses FcRL4 (receptor for IgA)
- These B cells produce RANKL which can damage joints – induces formation of osteoclasts which degrade bone
- Rituximab is a monoclonal antibody that depletes B cells – can be used for RA patients to prevent B cell-induced bone damage by reducing RANKL production in the joint

20
Q

how do FcRL4+ B cells contribute to RA inflammation?

A

FcRL4 is an IgA receptor, and these pathogenic B cells were enriched with IgA, acting as though they were at the mucosa
- Mucosal phenotype of B cells present at the joint, contributing to inflammation

21
Q

are these FcRL4+ B cells specific for a particular antigen?

A

Cloned recombinant antibodies from FcRL4+ B cells with same the antigen-binding site from RA patients into vectors and ran over ELISA for CCPs
- Showed that FcRL4+ B cells were enriched for recognition of CCP autoantigens
- Not high-affinity antibodies, but there is reactivity to CCPs from this B cell subset – association of B cell mucosal immune response within the joint

22
Q

what are the FcRL4+ B cells enriched for on their surface? what does this enable?

A

FcRL4 isotype of these B cells from RA synovial fluid were enriched for IgA1, even though they’re not at the mucosa
- IgA immune complexes can be internalised by the FcRL4 B cells – act as APC
- These complexes are then presented to T cells
- Both specificity and ability to capture IgA isotype suggests FcRL4 B cell role in autoimmunity

23
Q

Do FcRL4+ B cells link joint and bowel inflammation?

A

FcRL4 B cells found in the inflamed gut and in synovial fluid
- Inflammatory bowel disease patients have increased risk of RA – maybe due to FcRL4+ B cells

24
Q

can FcRL4+ B cells be targeted?

A
  • this receptor is specifically expressed on these B cells
  • high-specificity target, so less side effects
  • delete these cells and their mucosal inflammatory role in RA
25
Q

how was the role of FcRL4+ B cells in gut inflammation studied?

A

Sorted FcRL4+ and - cells
- Cloned recombinant IgA antibodies
- tested which of these antibodies recognised bacteria with flow cytometry
- labelled the antibodies from stool samples
- sorted bacteria which were labelled with antibody using FACS
- Sequenced sorted bacteria

26
Q

do antibodies from RA joint B cells recognise gut bacteria?

A

Some antibody clones from B cells recognise subgroups of bacteria

But:
- Particles of bacteria may travel into joint?
- Or B cells from gut travel into joint?

27
Q

how do B cells from the RA joint recognise bacteria?

A

Tiny particles 20nm are shed by bacteria which can travel through body barriers
- Is there enrichment of these particles in joints of RA patients and do they trigger local inflammation?

28
Q

is there a link between mucosal and joint inflammation?

A

Strong link between mucosal inflammation and arthritis via FcRL4+ B cells
- IgA+ B cells overrepresented in FcRL4+ population, found in inflamed mucosa and synovium
- can capture IgA immune complexes in mucosa and synovium, enabling ACPA repsonse
- Caused by travelling cells from site to site which may or may not be caused by bacteria
- The B cells produce cytokines such as RANKL which can cause damage
- FcRL4+ B cell subset may travel from mucosal inflammation or develop in joint – in both cases showing strong link to bacterial infection